Current position:Home >Product >
1,2-O-(1-methylethylidene)-3-O-[(4-methylphenyl)sulfonyl]hexofuranose
1,2-O-(1-methylethylidene)-3-O-[(4-methylphenyl)sulfonyl]hexofuranose(2946-01-2)
- Name: 1,2-O-(1-methylethylidene)-3-O-[(4-methylphenyl)sulfonyl]hexofuranose
- Synonyms:
- Molecular Formula:C16H22O8S
- Molecular Weight:374.412
- CAS Registry Number:2946-01-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.2946-01-2 1-[7,7-dimethyl-4-(4-methylphenyl)sulfonyloxy-2,6,8-trioxabicyclo[3.3.0]oct-3-yl]ethane-1,2-diol
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.2946-01-2 1-[7,7-dimethyl-4-(4-methylphenyl)sulfonyloxy-2,6,8-trioxabicyclo[3.3.0]oct-3-yl]ethane-1,2-diol
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.2946-01-2 1,2-O-Isopropylidene-伪-D-glucofuranose 3-tosylate
Assay:95% Appearance:Yellow Solid Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 90763-45-4/Benzamide, 5-((aminosulfonyl)methylamino)-4-chloro-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-
- 343-00-0/2-fluoro-9H-fluoren-9-ol
- 84836-87-3/Alcohols, C11-14-secondary, beta-((2-aminoethyl)amino)
- 200402-32-0/Benzoic acid,4-[[6-(pentamethyldisiloxanyl)- hexyl]oxy]-,4'-[(1-methylhexyl)oxy]-3'-nitro- [1,1'-biphenyl]-4-yl ester
- 5915-45-7/N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-(phenylsulfonyl)benzamide
- 61589-53-5/1,5-anhydro-2,3,4,6-tetradeoxy-2-[(diphenylacetyl)amino]-1,1,5-trimethyl-6-pyrrolidin-1-ylhexitol
- 67621-57-2/Vicein
- 125229-73-4/2-Propenoic acid, polymer with 1,3-butadiene and 2-propenenitrile, (1-cyano-4-(2-hydroxy-3-((2-methyl-1-oxo-2-propenyl)oxy)propoxy)-1-methyl-4-oxobutyl)-terminated
- 94837-49-7/22,23-Dihydroavermectin B1(a)
- 6292-31-5/dodecane-1-sulfonic acid; ethyl-dimethyl-[2-[2-(4-octylphenoxy)ethoxy]ethyl]azanium
- 80696-68-0/Pregnane-3,11,12-triol,14,20:18,20-diepoxy-,12-acetate 11-[(2E)-3-phenyl-2-propenoate],(3â,5R,11R,12â,14â,20S)-
- 94094-32-3/N,N-Bis(2-hydroxyethyl)palmitamide acetate
- 68958-40-7/Pyridinium, 3-ethenyl-1-methyl-, chloride, polymer with 5-ethenyl-2-methylpyridine
- 123041-25-8/3-Methylbutan-2-yl nitrate
- 190-07-8/Benzo[a]phenaleno[1,9-hi]acridine
- 50887-69-9/Orotic acid monohydrate
- 93964-62-6/trisodium hydrogen 5-[[4'-[[8-[[2,4-dihydroxy-3-[(2-methoxy-5-sulphonatophenyl)azo]phenyl]azo]-1-hydroxy-3,6-disulphonato-2-naphthyl]azo]-3,3'-dimethoxy[1,1'-biphenyl]-4-yl]azo]salicylate
- 77743-24-9/Cuprate(3-),[2-[[[[3-amino-2-(hydroxy-kO)-5-sulfophenyl]azo-kN2]phenylmethyl]azo-kN1]-4-sulfobenzoato(5-)-kO]-,trisodium (9CI)
- 63617-46-9/4-(diethylamino)-5-methyl-3,6-diphenyl-2H-pyran-2-one
- 2946-01-2/1,2-O-(1-methylethylidene)-3-O-[(4-methylphenyl)sulfonyl]hexofuranose
- 94035-77-5/(2Z,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl (5E,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
- 71832-84-3/3,3'-[(2-Chloro-5-methyl-1,4-phenylene)bis[iminocarbonyl(2-hydroxy-3,1-naphthalenediyl)azo]]bis[4-methylbenzoic acid 1-methylethyl] ester
- 91725-04-1/7-methoxy-4-methyl-2-(methylsulfanyl)-1H-imidazo[4,5-d]pyridazine
- 96009-51-7/S-ethyl (3-methyl-2-phenylbutyl)carbamothioate
- 76919-59-0/(6-methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-5-yl)methyl ethylcarbamate
- 72236-24-9/4-({[4-(acetylamino)phenyl]sulfonyl}amino)benzoic acid
- 86003-55-6/Nikkomycin
- 52059-64-0/5-(3-fluorophenyl)-1,3,4-oxathiazol-2-one
- 73138-61-1/Fatty acids, tallow, polymers with bisphenol A, diethanolamine, epichlorohydrin, 2-hydroxyethyl methacrylate, methacrylic acid, TDI, 3a,4,7,7a-tetrahydro-1,3-isobenzofurandione and triethylamine
- 6055-08-9/{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)amino]phenyl}(phenyl)methanone